/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Bausch Health Companies Inc Share Price Today: Live Updates & Key Insights

Bausch Health Companies Inc share price today is $5.08, up -7%. The stock opened at $5.35 against the previous close of $5.43, with an intraday high of $5.35 and low of $5.035.

Bausch Health Companies Inc Share Price Chart

style
pb-0

Bausch Health Companies Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Bausch Health Companies Inc Share Price Performance

$5.08 -0.07(-7%) BHC at 13 Mar 2026 12:12 PM Drug Manufacturers - Specialty & Generic
Lowest Today 5.035
Highest Today 5.35
Today’s Open 5.35
Prev. Close 5.43
52 Week High 8.69
52 Week Low 4.25
Day’s Range: Low 5.035 High 5.35
52-Week Range: Low 4.25 High 8.69
1 day return -
1 Week return -6.31
1 month return -15.84
3 month return -26.93
6 month return -29.78
1 year return -26.98
3 year return -36.54
5 year return -85.08
10 year return -

Bausch Health Companies Inc Institutional Holdings

Paulson & Company Inc 19.77

Goldentree Asset Management LP 9.40

Nomura Holdings Inc 4.24

Vanguard Group Inc 2.88

Royal Bank of Canada 2.84

HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 2.28

NATIONAL BANK OF CANADA /FI/ 2.08

MFN Partners Management, LP 1.62

Kohlberg Kravis Roberts & Co LP 1.41

UBS Group AG 1.39

Hudson Bay Capital Management LP 1.35

ING Groep NV 1.35

Loomis Sayles MFD Class C 1.17

Vanguard Total Intl Stock Index Inv 1.02

NORGES BANK 0.99

Mitsubishi UFJ Securities International PLC 0.92

Dimensional Fund Advisors, Inc. 0.88

Macquarie Group Ltd 0.88

The Goldman Sachs Group Inc 0.84

SG Americas Securities, LLC 0.80

Arrowstreet Capital Limited Partnership 0.74

Loomis Sayles Strategic Alpha 0.70

Vanguard Developed Markets Index Admiral 0.65

Charles Schwab Investment Management Inc 0.55

Fidelity Canadian Value ETF 0.54

Vanguard Instl Ttl Intl Stk Mkt Idx TrII 0.51

Fidelity Canadian High Quality ETF 0.49

iShares Core S&P/TSX Capped Compost ETF 0.39

Dimensional Canadian Small Company 0.37

DFA International Small Company I 0.37

Schwab Fundamental International Eq ETF 0.34

Vanguard FTSE All-Wld ex-US SmCp Idx Ins 0.25

RBC QUBE Canadian Equity F 0.22

BMO S&P/TSX Capped Composite ETF 0.22

Core Plus Full Discretion CIT D 0.21

Loomis Sayles CPFD CIT 0.21

Loomis Sayles Inv Grade Bond CIT 0.21

State St Gbl Sm Cp Eq ex-US Indx NL Cl A 0.21

Vanguard FTSE Canada All Cap ETF 0.21

BLK CDN MSCI Can IMI Ext ESG Fcs Idx A 0.18

Bausch Health Companies Inc Market Status

Strong Buy: 0

Buy: 1

Hold: 5

Sell: 1

Strong Sell: 0

Bausch Health Companies Inc Fundamentals

Market Cap 2015.91 M

PB Ratio 18.7773

PE Ratio 12.9286

Enterprise Value 21552.05 M

Total Assets 26318.02 M

Volume 2604540

Bausch Health Companies Inc Company Financials

Annual Revenue FY25:10308978075 10309.0M, FY24:9518000000 9518.0M, FY23:8542000000 8542.0M, FY22:8124000000 8124.0M, FY21:8434000000 8434.0M

Annual Profit FY25:7044084180 7044.1M, FY24:6736000000 6736.0M, FY23:6036000000 6036.0M, FY22:5760000000 5760.0M, FY21:6040000000 6040.0M

Annual Net worth FY25:155278418 155.3M, FY24:-46000000 -46.0M, FY23:-963000000 -963.0M, FY22:-212000000 -212.0M, FY21:-937000000 -937.0M

Quarterly Revenue Q4/2025:2838978075 2839.0M, Q3/2025:2681000000 2681.0M, Q2/2025:2530000000 2530.0M, Q1/2025:2259000000 2259.0M, Q4/2024:2559000000 2559.0M

Quarterly Profit Q4/2025:1789084180 1789.1M, Q3/2025:1931000000 1931.0M, Q2/2025:1766000000 1766.0M, Q1/2025:1558000000 1558.0M, Q4/2024:1832000000 1832.0M

Quarterly Net worth Q4/2025:-113721582 -113.7M, Q3/2025:179000000 179.0M, Q2/2025:148000000 148.0M, Q1/2025:-58000000 -58.0M, Q4/2024:93000000 93.0M

About Bausch Health Companies Inc & investment objective

Company Information Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Organisation Drug Manufacturers - Specialty & Generic

Employees 20300

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Thomas J. Appio

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow